Liu Long, Dai Hua-Ping, Xiao Bai, Zhang Shu, Ban Cheng-Jun, Xin Ping
Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Diseases, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
Zhonghua Yi Xue Za Zhi. 2009 Oct 20;89(38):2690-4.
To examine whether there was an association between epithelial neutrophil activating peptide 78 (ENA-78), interferon-inducible protein 10 (IP-10), vascular endothelial growth factor (VEGF) polymorphism and Chinese patients with idiopathic pulmonary fibrosis (IPF).
Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were performed to analyze the gene polymorphisms of ENA-78 (-156G/C), IP-10 (-1596C/T) and VEGF (+405G/C) in 60 IPF patients and 60 controls with trauma or bone fracture matched in age, gender and smoking status.
The distribution of carrying GC + CC genotype frequency (20.0%) and C allele frequency (12.7%) for ENA-78 in IPF patients was significantly higher than that in healthy controls [6.7% (P = 0.032) and 3.3% (P = 0.008), respectively], the relative risk of suffering from IPF of -156C allele gene carrier significantly increased (OR = 4.23, 95%CI: 1.35-13.20). The distribution of carrying CT + TT genotype frequency (10.0%) and T allele frequency (5.8%) for IP-10 in IPF patients was significantly lower than that in healthy controls [26.7% (P = 0.018) and 14.2% (P = 0.031), respectively], the relative risk of suffering from IPF of -1596T allele gene carrier decreased (OR = 0.38, 95%CI: 0.15-0.95). No association was found between VEGF (+405G/C) polymorphism and IPF.
-156C allele for ENA-78 may be a risk factor of IPF and -1596T allele for IP-10 a beneficial factor of IPF. The VEGF (+405G/C) gene polymorphism has no effect upon the predisposition to IPF.
探讨上皮中性粒细胞激活肽78(ENA-78)、干扰素诱导蛋白10(IP-10)、血管内皮生长因子(VEGF)基因多态性与中国特发性肺纤维化(IPF)患者之间的关系。
采用聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)方法,分析60例IPF患者及60例年龄、性别、吸烟状况相匹配的创伤或骨折对照者的ENA-78(-156G/C)、IP-10(-1596C/T)和VEGF(+405G/C)基因多态性。
IPF患者中ENA-78携带GC+CC基因型频率(20.0%)和C等位基因频率(12.7%)的分布显著高于健康对照者[分别为6.7%(P=0.032)和3.3%(P=0.008)],-156C等位基因携带者患IPF的相对风险显著增加(OR=4.23,95%CI:1.35-13.20)。IPF患者中IP-10携带CT+TT基因型频率(10.0%)和T等位基因频率(5.8%)的分布显著低于健康对照者[分别为26.7%(P=0.018)和14.2%(P=0.031)],-1596T等位基因携带者患IPF的相对风险降低(OR=0.38,95%CI:0.15-0.95)。未发现VEGF(+405G/C)基因多态性与IPF之间存在关联。
ENA-78的-156C等位基因可能是IPF的危险因素,IP-10的-1596T等位基因可能是IPF的有益因素。VEGF(+405G/C)基因多态性对IPF的易感性无影响。